These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30513818)

  • 41. [The efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes with glycosylated hemoglobin A1c > 9].
    Yan L; Wang S; Chen P; Chen C; Shao Z; Xu X; Huang Q
    Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):307-12. PubMed ID: 26268058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment.
    Di Sabatino A; Santilli F; Guerci M; Simeone P; Ardizzone S; Massari A; Giuffrida P; Tripaldi R; Malara A; Liani R; Gurini E; Aronico N; Balduini A; Corazza GR; Davì G
    Thromb Haemost; 2016 Aug; 116(3):486-95. PubMed ID: 27305860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
    Davi G; Alessandrini P; Mezzetti A; Minotti G; Bucciarelli T; Costantini F; Cipollone F; Bon GB; Ciabattoni G; Patrono C
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3230-5. PubMed ID: 9409316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.
    Fujishima Y; Maeda N; Inoue K; Kashine S; Nishizawa H; Hirata A; Kozawa J; Yasuda T; Okita K; Imagawa A; Funahashi T; Shimomura I
    Cardiovasc Diabetol; 2012 Sep; 11():107. PubMed ID: 22973968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.
    Puccetti L; Santilli F; Pasqui AL; Lattanzio S; Liani R; Ciani F; Ferrante E; Ciabattoni G; Scarpini F; Ghezzi A; Auteri A; Davì G
    Atherosclerosis; 2011 Jan; 214(1):122-8. PubMed ID: 21056418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry.
    Cavalca V; Minardi F; Scurati S; Guidugli F; Squellerio I; Veglia F; Dainese L; Guarino A; Tremoli E; Caruso D
    Anal Biochem; 2010 Feb; 397(2):168-74. PubMed ID: 19825360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of addition of liraglutide to high-dose intensive insulin therapy: a randomized prospective trial.
    Lane W; Weinrib S; Rappaport J; Hale C
    Diabetes Obes Metab; 2014 Sep; 16(9):827-32. PubMed ID: 24589127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials.
    von Scholten BJ; Davies MJ; Persson F; Hansen TW; Madsbad S; Endahl L; Jepsen CH; Rossing P
    J Diabetes Complications; 2017 Jul; 31(7):1164-1168. PubMed ID: 28462892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day].
    Sklyanik IA; Shestakova MV
    Ter Arkh; 2021 Oct; 93(10):1203-1208. PubMed ID: 36286822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.
    Lane W; Weinrib S; Rappaport J
    Diabetes Technol Ther; 2011 May; 13(5):592-5. PubMed ID: 21406014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of vitamin C on the relationship among inflammation, lipid peroxidation and platelet activation during analgesic nephropathy in rats.
    Hadzi-Petrushev N; Mitrov D; Kostovski V; Mladenov M
    J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):473-481. PubMed ID: 28771433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus.
    Santilli F; Liani R; Di Fulvio P; Formoso G; Simeone P; Tripaldi R; Ueland T; Aukrust P; Davì G
    Thromb Haemost; 2016 Nov; 116(6):1089-1099. PubMed ID: 27709225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis.
    McAdam-Marx C; Nguyen H; Schauerhamer MB; Singhal M; Unni S; Ye X; Cobden D
    Clin Ther; 2016 Dec; 38(12):2642-2651. PubMed ID: 27889301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
    Katoh K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of 12-week moderate aerobic exercise on ROCK2 activity, hs-CRP and glycemic index in obese patients with impaired glucose tolerance.
    Kargarfard M; Nobari H; Kamyar K; Zadeh AK; Oliveira R
    Physiol Behav; 2022 Dec; 257():113976. PubMed ID: 36183850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of platelet activation in hypertensives with microalbuminuria.
    Guagnano MT; Ferroni P; Santilli F; Paoletti V; Manigrasso MR; Pescara L; Cuccurullo C; Ciabattoni G; Davì G
    Free Radic Biol Med; 2009 Apr; 46(7):922-7. PubMed ID: 19280705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury.
    Wang JS; Yang CF; Wong MK; Chow SE; Chen JK
    Thromb Haemost; 2000 Jul; 84(1):118-23. PubMed ID: 10928481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
    Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.
    Lattanzio S; Santilli F; Liani R; Vazzana N; Ueland T; Di Fulvio P; Formoso G; Consoli A; Aukrust P; Davì G
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.